City

City of Austin Office of the Chief Medical Officer

Current148 dose entries33 drugs1 documentAustin, TXeffective 2024-12-0199% machine-parsed of 148

City of Austin Office of the Chief Medical Officer (Austin, TX) carries 33 drugs across 148 dose entries in its current published protocol, effective 2024-12-01.

Drugs and doses33

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	650 mg	PO	not captured	standing	page 319
Mild to moderate pain	peds	650 mg	PO	not captured	standing	page 319

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	12 mg	IV/IO	not captured	standing	page 320
SVT	peds	0.2 mg/kg	IV/IO	not captured	standing	page 320

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 MDI Puffs	NEB	not captured	standing	page 322
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	page 322
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	page 322
Hyperkalemia	adult	10 mg	NEB	not captured	standing	page 322

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	300 mg	IV/IO	not captured	standing	page 323
Other	peds	5 mg/kg	IV/IO	not captured	standing	page 323
Post-ROSC care	adult	150 mg	IV/IO	not captured	standing	page 323
Post-ROSC care	peds	5 mg/kg	IV/IO	not captured	standing	page 323

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
STEMI	adult	234 mg	PO	not captured	standing	page 325

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.8 mg	IV/IO	not captured	standing	pages 326, 327
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 326, 327
Organophosphate poisoning	adult	2 mg	IM	not captured	standing	pages 326, 327
Organophosphate poisoning	adult	2 mg	IV/IO/IM	not captured	standing	pages 326, 327
Organophosphate poisoning	peds	0.02 mg/kg	IV/IO/IM	not captured	standing	pages 326, 327
Organophosphate poisoning	peds	0.5 mg	IM	not captured	standing	pages 326, 327

Buprenorphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	8 mg	PO	not captured	standing	page 330

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV/IO	not captured	standing	page 331
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	page 331
Burns	adult	1 g	IV/IO	not captured	standing	page 331
Cardiac arrest	adult	1 g	IV/IO	not captured	standing	page 331
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	page 331
Other	peds	10 mg/kg	IV/IO	not captured	standing	page 331

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	10 mg	IV/IO/IM	not captured	standing	page 333
Anaphylaxis	peds	0.6 mg/kg	IV/IO/IM	not captured	standing	page 333
Anaphylaxis	peds	0.6 mg/kg	PO	not captured	standing	page 333
Respiratory distress	adult	10 mg	IV/IO/IM	not captured	standing	page 333
Respiratory distress	peds	0.6 mg/kg	IV/IO/IM	not captured	standing	page 333

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV/IO	not captured	standing	page 335
Hypoglycemia	peds	1 g/kg	IV/IO	not captured	standing	page 335
Neonatal resuscitation	peds	1 g/kg	IV/IO	not captured	standing	page 335

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	0.25 mg/kg	IV/IO	not captured	standing	page 336

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25 mg	PO	not captured	standing	page 338
Allergic reaction	adult	25 mg	IV/IO/IM	not captured	standing	page 338
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 338
Nausea / vomiting	adult	25 mg	IV/IO/IM	not captured	standing	page 338
Nausea / vomiting	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 338
Other	adult	25 mg	IV/IO/IM	not captured	standing	page 338

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IV/IO/IM	not captured	standing	page 340
Nausea / vomiting	adult	0.5 mL	IV/IO/IM	not captured	standing	page 340
Other	adult	1.25 mg	IV/IO/IM	not captured	standing	page 340

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 341, 342
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 341, 342
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 341, 342
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 341, 342
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	page 342
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 341, 342
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 341, 342
Hypotension / shock	adult	20 mcg	IV/IO	not captured	standing	page 341
Respiratory distress	peds	0.5 mg	NEB	not captured	standing	pages 341, 342

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	25–100 mcg	IV/IO/IM/IN	not captured	standing	page 345
Crush injury	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 345
Mild to moderate pain	adult	25–100 mcg	IV/IO/IM/IN	not captured	standing	page 345
Mild to moderate pain	peds	1.5–2 mcg/kg	IV/IO/IM/IN	not captured	standing	page 345
Procedural sedation	adult	25–100 mcg	IV/IO/IM/IN	not captured	standing	page 345
Procedural sedation	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 345
STEMI	adult	25–100 mcg	IV/IO/IM/IN	not captured	standing	page 345

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	4 mg	IV/IO	not captured	standing	page 347
Hypoglycemia	adult	1 mg	IM	not captured	standing	page 347
Hypoglycemia	peds	0.1 mg/kg	IM	not captured	standing	page 347

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 348
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	page 348

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	400 mg	PO	not captured	standing	page 349
Mild to moderate pain	adult	400 mg	PO	not captured	standing	page 349

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Organophosphate poisoning	adult	0.5 mg	NEB	not captured	standing	page 350
Organophosphate poisoning	peds	0.5 mg	NEB	not captured	standing	page 350
Other	adult	0.5 mg	NEB	not captured	standing	page 350
Other	peds	0.5 mg	NEB	not captured	standing	page 350
Respiratory distress	adult	0.5 mg	NEB	not captured	standing	page 350
Respiratory distress	peds	0.5 mg	NEB	not captured	standing	page 350

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	200 mg	IM	not captured	standing	page 352
Mild to moderate pain	peds	0.2 mg/kg	IV/IO	not captured	standing	page 353
Mild to moderate pain	peds	0.4 mg/kg	IM	not captured	standing	page 353
Procedural sedation	adult	100 mg	IV/IO	not captured	standing	pages 352, 353
Procedural sedation	peds	1 mg/kg	IV/IO	not captured	standing	pages 352, 353
RSI induction	adult	200 mg	IV/IO	not captured	standing	pages 352, 353
RSI induction	peds	2 mg/kg	IV/IO	not captured	standing	pages 352, 353

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	IV/IO	not captured	standing	page 355
Other	adult	40 mg	IO	not captured	standing	page 355
Other	peds	0.5 mg/kg	IO	not captured	standing	page 355
Mild to moderate pain	adult	100 mg	TOP	not captured	standing	page 355
Mild to moderate pain	peds	100 mg	TOP	not captured	standing	page 355
VF / pulseless VT	adult	100 mg	IV/IO	not captured	standing	page 355
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	page 355

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	4 g	IV/IO	not captured	standing	page 357
Other	adult	2 g	IV/IO	not captured	standing	page 357
Other	peds	50 mg/kg	IV/IO	not captured	standing	page 357
Respiratory distress	adult	2 g	IV/IO	not captured	standing	page 357
Respiratory distress	peds	50 mg/kg	IV/IO	not captured	standing	page 357
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	page 357
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	page 357
VF / pulseless VT	peds	50 mg/kg	IV/IO	not captured	standing	page 357
VF / pulseless VT	peds	50 mg/kg	IV/IO	not captured	standing	page 357

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	1.25–5 mg	IV/IO	not captured	standing	page 359
ACS / chest pain	adult	5–10 mg	IM/IN	not captured	standing	page 359
Agitation	adult	2.5–5 mg	IV/IO	not captured	standing	page 359
Agitation	adult	5–10 mg	IM/IN	not captured	standing	page 359
Other	adult	2.5–5 mg	IV/IO	not captured	standing	page 359
Other	adult	5 mg	IV/IO	not captured	standing	page 359
Other	adult	5–10 mg	IM/IN	not captured	standing	page 359
Other	peds	0.05 mg/kg	IV/IO	not captured	standing	page 359
Procedural sedation	adult	2–2.5 mg	IV/IO/IM/IN	not captured	standing	page 15
RSI induction	adult	5–10 mg	IV/IO	not captured	standing	page 359
Seizure	adult	10 mg	IM/IN	not captured	standing	page 359
Seizure	adult	5 mg	IV/IO	not captured	standing	page 359

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4–2 mg	IM	not captured	standing	page 361
Opioid overdose	adult	0.4–2 mg	IV/IO	not captured	standing	page 361
Opioid overdose	peds	0.1 mg/kg	IN	not captured	standing	page 361
Opioid overdose	peds	0.1 mg/kg	IM	not captured	standing	page 361
Opioid overdose	peds	0.1 mg/kg	IV/IO	not captured	standing	page 361

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL/TOP	not captured	standing	page 363
CHF / pulmonary edema	adult	1.2 mg	SL	not captured	standing	page 363

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	2–12 mcg	IV/IO	not captured	standing	page 364
Other	adult	2–12 mcg	IV/IO	not captured	standing	page 364
Other	adult	2–20 mcg	IV	not captured	standing	page 341
Post-ROSC care	adult	2–12 mcg	IV/IO	not captured	standing	page 364
Sepsis	adult	2–12 mcg	IV/IO	not captured	standing	page 364

Olanzapine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5–10 mg	SL	not captured	standing	page 366
Other	adult	10 mg	SL	not captured	standing	page 366

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	PO	not captured	standing	page 367
Nausea / vomiting	adult	4 mg	IV/IO/IM	not captured	standing	page 367
Nausea / vomiting	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 367
Nausea / vomiting	peds	4 mg	PO	not captured	standing	page 367

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO	not captured	standing	page 369
Hypoglycemia	peds	7.5 g	PO	not captured	standing	page 369

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IM	not captured	standing	page 371
Nerve agent exposure	adult	600 mg	IV/IO	not captured	standing	page 371
Nerve agent exposure	peds	15 mg/kg	IM	not captured	standing	page 371

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	50 mg	IV/IO	not captured	standing	page 372
Post-intubation sedation	adult	50 mg	IV/IO	not captured	standing	page 372
Post-ROSC care	adult	50 mg	IV/IO	not captured	standing	page 372
RSI induction	adult	100 mg	IV/IO	not captured	standing	pages 372, 353
RSI induction	peds	2 mg/kg	IV/IO	not captured	standing	pages 372, 353

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	100 mEq	IV/IO	not captured	standing	page 373
Crush injury	adult	100 mEq	IV/IO	not captured	standing	page 373
Hyperkalemia	adult	50 mEq	IV/IO	not captured	standing	page 373
Other	peds	1 mEq/kg	IV/IO	not captured	standing	page 373
Tricyclic overdose	adult	50 mEq	IV/IO	not captured	standing	page 373
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	page 373

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	1 g	IN/TOP	not captured	standing	page 375
Trauma / hemorrhage	adult	1 g	NEB	not captured	standing	page 375
Trauma / hemorrhage	adult	2 g	IV/IO	not captured	standing	page 375
Trauma / hemorrhage	peds	15 mg/kg	IN/TOP	not captured	standing	page 375
Trauma / hemorrhage	peds	15 mg/kg	NEB	not captured	standing	page 375
Trauma / hemorrhage	peds	15 mg/kg	IV/IO	not captured	standing	page 375

Cite this

City of Austin Office of the Chief Medical Officer, United States EMS Protocol Census. 148 dose entries, effective 2024-12-01.

https://protoquiz.com/census/agencies/city-of-austin-office-of-the-chief-medical-officer/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.